Sign Up for Our E-Newsletter

What’s Happening?

Who Determines Your Treatment Plan? It Might Not Be Your Doctor

Posted on May 20, 2015

medical bottles

Clinical pathways, sometimes known as care pathways, are detailed plans that outline the treatment a cancer patient will receive. These pathways can help to ensure patients receive the best possible care based on the most recent scientific data. However, treatment is not a one-sized-fits-all sort of thing and some individuals may perform better on a treatment plan that is customized to their unique situation. Let’s break it down and discuss both sides of the clinical pathway issue.

Read more

Sedasys: The Machine that Sedates

Posted on May 18, 2015


Imagine a day when you go in for a colonoscopy and a machine, not a person, sedates you. You may be familiar with this reality if you’ve come across Sedasys—an FDA-approved anesthesiology machine developed by Johnson & Johnson.

Read more

Never Too Young Represents at CancerCon

Posted on May 6, 2015

Never Too Young

What’s up with those Never Too Young shirts? We’re glad you asked! We rolled out our new shirts at StupidCancer’s CancerCon in Denver last month and we’re excited to be selling these in our online store. This slogan is our rally cry for the Never Too Young Coalition, where we’ve teamed up to spread the message that you’re never too young for colon cancer.

Read more

Blue Star Concert Hits the High Note for Awareness

Posted on May 1, 2015

Alessandro Taverna

We had a great time at last night’s Blue Star Concert in DC! The brainchild of Riccardo De Marchi Trevisan in memory of his mother Daniela Trevisan, the concert raised awareness and funds for colon cancer.

Read more

Colon Health Alert: FDA Approves Second-Line Use of Cyramza

Posted on May 1, 2015

Colon Health Alert_square

Eli Lilly and Company recently announced that the FDA has approved the use of Cyramza with FOLFIRI as a second-line treatment for colorectal cancer. This treatment, previously approved for use with advanced or metastatic gastric and lung cancer, now provides metastatic colorectal cancer patients with another biologic to use in the fight against their disease.

Read more